Use of inhibitors of Brutons tyrosine kinase (Btk) Grant US-11672803-B2 United States of America 13 Jun 2023
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10961251-B1 United States of America 30 Mar 2021
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) Grant US-10954567-B2 United States of America 23 Mar 2021
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-10828259-B2 United States of America 10 Nov 2020
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10751342-B2 United States of America 25 Aug 2020
Crystalline forms of a brutons tyrosine kinase inhibitor Grant US-10752634-B2 United States of America 25 Aug 2020
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant US-10653696-B2 United States of America 19 May 2020
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant US-10478439-B2 United States of America 19 Nov 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10294232-B2 United States of America 21 May 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10294231-B2 United States of America 21 May 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10266540-B2 United States of America 23 Apr 2019
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-10213386-B2 United States of America 26 Feb 2019
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-10125140-B1 United States of America 13 Nov 2018
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-10106548-B2 United States of America 23 Oct 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-10065968-B2 United States of America 04 Sep 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10016435-B2 United States of America 10 Jul 2018
Methods for the treatment of HER2 amplified cancer Grant US-10016434-B2 United States of America 10 Jul 2018
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Grant US-10010507-B1 United States of America 03 Jul 2018
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant US-10004746-B2 United States of America 26 Jun 2018
Use of inhibitors of Bruton'S tyrosine kinase (Btk) Grant US-10004745-B2 United States of America 26 Jun 2018
Phospholipase C gamma 2 and resistance associated mutations Grant US-9885086-B2 United States of America 06 Feb 2018
Novel Formulations of a Bruton's Tyrosine Kinase Inhibitor Application US-20180028537-A1 United States of America 01 Feb 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-9828383-B1 United States of America 28 Nov 2017
Use of inhibitors of bruton'S tyrosine kinase (BTK) Grant US-9814721-B2 United States of America 14 Nov 2017
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant US-9801883-B2 United States of America 31 Oct 2017
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors Grant US-9795605-B2 United States of America 24 Oct 2017
Methods for the treatment of HER2 amplified cancer Grant US-9724349-B2 United States of America 08 Aug 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant US-9725455-B1 United States of America 08 Aug 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-9713617-B2 United States of America 25 Jul 2017
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant US-9655857-B2 United States of America 23 May 2017
Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors Grant US-9546172-B2 United States of America 17 Jan 2017
Pyrrolopyrimidine compounds as kinase inhibitors Grant US-9540385-B2 United States of America 10 Jan 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant US-9540382-B2 United States of America 10 Jan 2017
Methods for the treatment of HER2 amplified cancer Grant US-9415050-B2 United States of America 16 Aug 2016